EATG » News

Vieillir avec le VIH: Brussels-based organisations met to discuss about ageing with HIV

This week the European AIDS Treatment Group participated in a meeting on “Ageing with HIV: What challenges? What ways forward?”, organised by two francophone organisations based in Brussels that work…

The European AIDS Treatment Group supports the petition towards the next Global Fund Replenishment Conference

Ahead of the next conference to replenish the Global Fund in October 2019 in France, AIDES -together with collaborating organisations (Action Santé Mondiale / Global Health Advocates, Coalition PLUS, Équilibres & Populations, Médecins du…

Reporting from the 2nd Hep-C Community Summit (Lisbon, 18 September 2018)

The Hep-C Community Summit, organised by Correlation European Harm Reduction Network, has brought together people from the affected communities, advocates, researchers, healthcare providers, harm reduction practitioners, and policymakers to discuss…

EHVA: European HIV advocates discuss about new clinical study aiming to evaluate experimental strategies for the control of HIV infection

On Thursday, 15th of November, the European AIDS Treatment Group hosted a meeting with members of HIV organisations from six European countries to discuss the launch of the study EHVA…

HIV Outcomes: Online Compendium of Good Practices for the long-term health of people living with HIV launched

BRUSSELS: Today, HIV Outcomes launched an Online Compendium of Good Practices for securing the long-term health and well-being of people living with HIV.   Although people with HIV can now anticipate…

EmERGE: Community Meeting for the Last Phase of the Project (Madrid – November 7 2018)

The EmERGE project (about developing a mHealth platform for self-management of HIV and reducing face-to-face consultations), funded by the European Commission, has started its last 18 months. The European AIDS…

14 Patient Organisations Call for Meaningful Involvement in European Cooperation on Health Technology Assessment (HTA)

Today, 14 European patient organisations & federations have launched a statement calling on European institutions to adopt appropriate measures to fully incorporate meaningful involvement of patients in EU cooperation on…

The EATG publishes its position paper on drugs policy

Today, on the occasion of the joint meeting of the EU Civil Society Forum on HIV, Hepatitis and TB and the EU Civil Society Forum on Drugs, the European AIDS…

The EATG in the Civil Society Fora joint meetings (Brussels 6-8 November)

From 6-8 November, the EATG will be actively engaged in developing joint advocacy, sharing with and learning from civil society partners across Europe within the EU Civil Society Forum  on…

HIV Drug Therapy 2018 Congress – Quality of Life Across Different Age Groups of People Living with HIV: A Community Perspective

The European AIDS Treatment Group had the opportunity to co-organise and co-chair the ‘Quality of Life Across Different Age Groups of PLHIV: A Community Perspective’ session during this year's HIV Drug Therapy…

STEPS V: HIV CURE COMMUNITY WORKSHOP IN GLASGOW

STEPS, a community initiative to design the pathway to a long-term remission of HIV infection, has reached its 5th edition in Glasgow. This year the theme of the meeting that was held…

HIV Outcomes meeting: Improving long-term health and well-being of people living with HIV (Brussels – 27 November 2018)

One year after the launch of policy recommendations in the European Parliament, the HIV Outcomes initiative returns with an event to launch a "virtual good practice clinic" on chronic HIV…

Join the EATG at the 2018 HIV Drug Therapy Congress in Glasgow

The European AIDS Treatment Group is present at the 2018 HIV Drug Therapy Congress in Glasgow, from the 28th to the 31st of October. As with the previous versions of…

Call for applications: Continuous Patient Education (CoPE) Special call about Living & Ageing with HIV (Quality of Life)

We are pleased to announce that a call for applications for CoPE is now open. Please find below detailed information on how to apply for this grant. The submission deadline…

HIV Travel: The Global Database on HIV-specific Travel and Residence restrictions is updated

The Global Database on HIV-specific Travel & Residence Restrictions, a useful online tool regarding the cross-border mobility of people living with HIV/AIDS, was recently updated. This is a joint collaboration…

M-Care 2018: Sharing the outcomes of the migrant advocates training programme

Today, Africa Advocacy Foundation (AAF) and the European AIDS Treatment Group (EATG) are launching the M-Care 2018 training programme report. Together with the report we are also launching a set of video…

The EU Civil Society Forum on HIV/AIDS, TB and viral hepatitis reacts to the relevant Commission Staff Working Document

GASTEIN - On 4 October -on the occasion of the European Health Forum discussion on Reaching the SDG targets on Health by 2030 - Actions needed to end AIDS & TB…

#JusticeForZak: sign the petition, join the campaign

On Friday 21 September, Zak Kostopoulos, died as a consequence of brutal beatings in Athens Greece. We call all relevant Greek authorities for a swift, thorough, independent and impartial investigation into…

We call on the authorities to ensure that justice for Zak Kostopoulos is done

On Friday 21 September, Zak Kostopoulos, died as a consequence of brutal beatings in Athens Greece. Zak was an HIV+, sex positive, queer, human rights’ activist and defender, also raising…

EATG General Assembly 2018 (Vilnius, 27-30 September)

The European AIDS Treatment Group is holding its annual General Assembly in Vilnius, Lithuania over the next four days. More than 75 members and the staff of EATG are gathering…

US insurers must now cover PrEP

An influential guidelines body in the United States has put its full weight behind pre-exposure prophylaxis (PrEP) to people at high risk of HIV. The grade A recommendation of the…

In unique case, Australian man appears to have cleared his HIV infection

Subject had an unusual combination of factors inhibiting HIV replication Researchers in Sydney, Australia have identified a patient who appears to have spontaneously cleared his own HIV infection without any…

Is it safe to alter the CCR5 receptor? And how will this influence HIV cure studies?

The HIV cure effort suffered a potential setback this week, as researchers reported an association between having two copies of the CCR5-∆32 mutation and shorter survival. Read the full blog post…

‘Motivational interview’ may lessen problem drinking in people with HIV

Brief intervention effective for patients resistant to reducing alcohol use, UCSF-Kaiser Permanente study shows A single, 45-minute “motivational interview” with two 20-minute follow-up phone calls may help people with HIV…

Women who inject drugs more likely to be living with HIV

Drug use is more common among men, with women accounting for just one in three people who use drugs and one in five people who inject drugs. However, women who…

UNAIDS welcomes the decision of the High Court of Botswana to repeal laws that criminalize and discriminate against LGBT people

GENEVA, 11 June 2019 — UNAIDS applauds the landmark decision of the High Court of Botswana to declare unconstitutional key provisions of Sections 164 and 167 of the Botswana Penal…

WHO’s ‘Treat All’ HIV recommendation led to increases in ART initiation in Africa

Large study of 'Treat All' policies for HIV in sub-Saharan Africa finds major improvements in rapid uptake of treatment A new study published in PLoS Medicine found that the adoption of the…

What’s behind PEPFAR’s funding cut threats?

BERLIN — As it wraps up its latest funding round, the President's Emergency Plan for AIDS Relief is prepared to introduce unprecedented cuts to country programs in sub-Saharan Africa, designed to spur…

ContraVir announces CRV431 data from experimental model of hepatitis B

ContraVir Pharmaceuticals announces publication of CRV431 data from experimental model of hepatitis B EDISON, N.J., June 11, 2019 -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development…

Checkmate for hepatitis B viruses in the liver

Researchers at Helmholtz Zentrum München and the Technical University of Munich, working in collaboration with researchers at the University Medical Center Hamburg-Eppendorf and the University Hospital Heidelberg, have for the…

WHO: Meeting global goals for HIV, hepatitis, STIs requires accelerated effort

More action is needed to meet goals to eliminate HIV, viral hepatitis, and sexually transmitted infections by 2030, according to a recently released World Health Organization (WHO) progress report. The…

Breaking down HIV exclusions in cancer clinical trials

As an eligibility barrier cracks, a lung cancer patient gets a new lease on life For reasons that date back to the earliest days of the AIDS epidemic, HIV-positive people…

Just 18% of people with hepatitis/HIV co-infection and cirrhosis are screened for liver cancer as often as recommended

There is a “strikingly low adherence” to clinical guidelines for ultrasound screening for hepatocellular carcinoma in Western Europe, researchers report in the Journal of Viral Hepatitis. Over years or decades,…

HIV drug cabotegravir not associated with weight gain

The novel integrase inhibitor cabotegravir — which is currently in development for both HIV prevention and treatment — was not associated with excess weight gain in HIV-uninfected patients compared with…

Performance of CVD Risk Prediction Algorithms in People Living With HIV

Algorithms may help predict cardiovascular disease (CVD) risk in people living with HIV (PLWHIV), according to a study published in the Journal of Acquired Immune Deficiency Syndromes. There is a higher…

Study Suggests Widespread PrEP Use Would Take a Big Bite Out of HIV

The study also projected that PrEP use among adult gay and bi men would result in considerable reductions of HIV among adolescents. A new, highly sophisticated mathematical modeling study projects…

Elbasvir/Grazoprevir: First-Line Therapy for Chronic HCV in DAA-Naive Patients?

Elbasvir (EBR) combined with grazoprevir (GZR) may be extremely useful as first-line therapy for chronic hepatitis C virus (HCV) infection in patients who are direct-acting antiviral (DAA) treatment-naive, according to…

More than 1 million new curable sexually transmitted infections every day

Every day, there are more than 1 million new cases of curable sexually transmitted infections (STIs) among people aged 15-49 years, according to data released today (June 6) by the…

UK, Germany, dissociate from WHO drug pricing resolution

The passage of a landmark resolution on improving the transparency of markets for medicines at the latest WHA fails to narrow the political divide. John Zarocostas reports from Geneva. Few…

HIV epidemic in children in Pakistan raises concern

The epidemic could be found to have reached adults as well. Experts suspect that it is a marker of systematic failures in health-care provision. Andrew Green reports. More than 730…